Faculty

Faculty

Barry S. Taylor, PhD

Human Oncology & Pathogenesis Program

Researcher Barry Taylor focuses on defining the somatic abnormalities that mediate the genesis, progression, and response to therapy of human cancers.

Cameron W. Brennan, MD

Human Oncology & Pathogenesis Program

The Brennan Lab

Physician-scientist Cameron Brennan focuses on genomic analysis of human and mouse gliomas and medulloblastomas.

Charles L. Sawyers, MD

Human Oncology & Pathogenesis Program

The Sawyers Lab

Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.

Christine A. Iacobuzio-Donahue, MD, PhD

Human Oncology & Pathogenesis Program

Physician-scientist Christine Iacobuzio-Donahue studies the genomics and cell biology of pancreatic and other solid tumors as it relates to subclonal evolution, tumor progression, and metastasis.

Christopher Y. Park, MD, PhD

Human Oncology & Pathogenesis Program

The Park Lab

Physician-scientist Christopher Park focuses on the identification and characterization of molecular pathways that regulate normal and malignant stem cells in the hematopoietic system.

David B. Solit, MD

Human Oncology & Pathogenesis Program

Pictured: Solit Lab

Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.

Emily H. Cheng, MD, PhD

Human Oncology & Pathogenesis Program

The Cheng Lab

Physician-scientist Emily Cheng focuses on the molecular mechanisms of cell death and their implications in tumorigenesis and cancer therapy, with primary emphasis on lung and kidney cancers.

Ingo K. Mellinghoff, MD

Human Oncology & Pathogenesis Program

The Mellinghoff Lab

Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.

James A. Fagin, MD

Human Oncology & Pathogenesis Program

The Fagin Lab

Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.

James J. Hsieh, MD, PhD

Human Oncology & Pathogenesis Program

The Hsieh Lab

Physician-scientist James Hsieh focuses on developing novel therapeutics targeting cancer cell proliferation; he also directs Memorial Sloan Kettering’s translational kidney cancer research program.